Nucleus Raises $20M in Series B Funding to Accelerate Industry Adoption of Unified Vulnerability Management.
We’re excited to announce that we’ve secured $20 million in Series B funding led by Lead Edge Capital. Also participating in the round is Arthur Ventures, a Series A investor of Nucleus. This funding will be used to accelerate product development and enhance customer experience, scale engineering and support services, expand our presence in APAC, as well as invest in our people and culture.
“Providing the best customer experience and the best risk-based vulnerability management platform for large enterprises remains our top priority. To accomplish this, we believe that it is key to be investing in our team and ensuring that Nucleus remains one of the best cybersecurity startups to work for,” said Steve Carter, co-founder and CEO, Nucleus. “This funding round is an exciting milestone for Nucleus, and we are grateful for the support of Lead Edge Capital and Arthur Ventures. Last year, we more than quadrupled our headcount and more than tripled our ARR, so we are just getting started on our mission to revolutionize vulnerability management.”
As a next-generation vulnerability management platform, Nucleus breaks down traditional silos of vulnerability information and enables large enterprises to implement a comprehensive intelligence-led vulnerability management program across the organization. Nucleus sits at the nexus of vulnerability data, asset information, and embedded threat intelligence – providing contextually relevant data and allowing for automated response at scale. Integrating with over 100 scanners and external tools, Nucleus unifies existing security stacks into one single platform for vulnerability teams to eliminate laborious manual data analysis, control the chaos of vulnerability triage, remediation and monitoring, and accelerate decision-making and prioritization.
“Organizations are overloaded with alerts from vulnerability tools and are struggling to figure out which vulnerabilities to fix that are going to be the most impactful. Nucleus is redefining the vulnerability management software category as a single source of record for all assets, vulnerabilities, and associated data,” added Avery Rosin from Lead Edge Capital, a growth equity fund that has made cyber security investments in high growth companies like Duo Security and Signal Sciences. “Nucleus helps organizations mature their vulnerability management programs, making teams more productive and driving better visibility across complex environments. The Nucleus platform is quite powerful, and there is a ton of opportunity as the team continues to deliver innovative capabilities to customers. We are excited to support the Nucleus team on the high growth path ahead.”
This funding arrives on the heels of early 2022 company news including Nucleus’ strategic partnership with Mandiant, and the appointment of Andrew Peterson to the Nucleus advisory board. Later this year, customers can expect more integrations, updates to the vulnerability workflow and automation engine, customizable views and dashboards, as well as stronger prioritization and remediation features within the Nucleus platform.